Omar A.

Omar A. has a solid work experience in the pharmaceutical and biotechnology industry. Omar currently holds the position of Vice President at Kestrel Therapeutics since February 2023. Before that, they worked at Roivant Sciences as an Executive Director from September 2022 to February 2023 and as a Senior Director from September 2021 to September 2022. Prior to Roivant Sciences, they were employed at Blueprint Medicines as a Principal Scientist/Associate Director from June 2020 to September 2021 and as a Senior Scientist II from August 2019 to June 2020. Omar A. also gained valuable experience at Pfizer, where they held various roles including Principal Scientist - Group Leader from February 2018 to July 2019 and from December 2016 to February 2018, Principal Scientist from August 2015 to November 2016, and Senior Scientist from April 2014 to August 2015. Their career started at DuPont as a Research Investigator from April 2012 to March 2014.

Omar A. holds a Bachelor's Degree in Chemistry from Brown University. Omar has also pursued further education and completed a Doctor of Philosophy (Ph.D.) in Organic Chemistry at the Massachusetts Institute of Technology.